BE899484A - NOVEL ANTIGENIC DETERMINANTS RELATED TO ADENOCARCINOMA AND ANTIBODIES THAT ARE SPECIFIC TO THEM. - Google Patents

NOVEL ANTIGENIC DETERMINANTS RELATED TO ADENOCARCINOMA AND ANTIBODIES THAT ARE SPECIFIC TO THEM.

Info

Publication number
BE899484A
BE899484A BE0/212811A BE212811A BE899484A BE 899484 A BE899484 A BE 899484A BE 0/212811 A BE0/212811 A BE 0/212811A BE 212811 A BE212811 A BE 212811A BE 899484 A BE899484 A BE 899484A
Authority
BE
Belgium
Prior art keywords
adenocarcinoma
specific
antibodies
antigenic determinants
novel antigenic
Prior art date
Application number
BE0/212811A
Other languages
French (fr)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of BE899484A publication Critical patent/BE899484A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Procédé se pretant au diagnostic d'un adénocarcinome humain par détermination de la matière antigénique apparentée à l'adénocarcinome dans un échantillon prélevé sur un patient humain, suivant lequel on utilise (a) un anticorps anti-K ou (b) un anticorps anti-p pour déterminer la matière dans l'échantillon ayant respectivement (a') exclusivement les déterminants antigènes K spécifiques des adénocarcinomes ou (b') les déterminants antigènes p associés aux déterminants K sur les adénocarcinomes.Method suitable for the diagnosis of a human adenocarcinoma by determination of the antigenic material related to adenocarcinoma in a sample taken from a human patient, according to which one uses (a) an anti-K antibody or (b) an anti-K p to determine the material in the sample having respectively (a ') exclusively the K antigen determinants specific for adenocarcinomas or (b') the p antigen determinants associated with the K determinants on adenocarcinomas.

BE0/212811A 1983-06-23 1984-04-20 NOVEL ANTIGENIC DETERMINANTS RELATED TO ADENOCARCINOMA AND ANTIBODIES THAT ARE SPECIFIC TO THEM. BE899484A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838317022A GB8317022D0 (en) 1983-06-23 1983-06-23 Adenocarcinoma related new antigenic determinants

Publications (1)

Publication Number Publication Date
BE899484A true BE899484A (en) 1984-10-22

Family

ID=10544654

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212811A BE899484A (en) 1983-06-23 1984-04-20 NOVEL ANTIGENIC DETERMINANTS RELATED TO ADENOCARCINOMA AND ANTIBODIES THAT ARE SPECIFIC TO THEM.

Country Status (13)

Country Link
JP (1) JPS6018765A (en)
AU (1) AU2017183A (en)
BE (1) BE899484A (en)
DE (1) DE3337465A1 (en)
DK (1) DK476083A (en)
FI (1) FI833742A7 (en)
FR (1) FR2548901A1 (en)
GB (1) GB8317022D0 (en)
IT (1) IT1194429B (en)
NL (1) NL8303571A (en)
NO (1) NO833756L (en)
SE (1) SE8305667L (en)
ZA (1) ZA837673B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2589630B2 (en) * 1992-06-12 1997-03-12 ゼニヤ海洋サービス株式会社 Water control device for sabo dam

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086217A (en) * 1976-03-03 1978-04-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4315851A (en) * 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0044167A3 (en) * 1980-07-14 1982-04-21 The Regents Of The University Of California Antibody targeted cytotoxic agent
EP0072902B1 (en) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
DE3230299A1 (en) * 1982-08-14 1984-02-16 Hoechst Ag, 6230 Frankfurt CARCINOEMBRYONALES ANTIGEN, METHOD FOR ITS INSULATION AND ITS USE

Also Published As

Publication number Publication date
FI833742L (en) 1984-12-24
JPS6018765A (en) 1985-01-30
AU2017183A (en) 1985-01-03
FI833742A0 (en) 1983-10-14
SE8305667D0 (en) 1983-10-14
DK476083D0 (en) 1983-10-14
FR2548901A1 (en) 1985-01-18
NO833756L (en) 1984-12-27
ZA837673B (en) 1984-08-29
SE8305667L (en) 1984-12-24
NL8303571A (en) 1985-01-16
IT8323351A0 (en) 1983-10-19
IT1194429B (en) 1988-09-22
FI833742A7 (en) 1984-12-24
DE3337465A1 (en) 1985-01-03
DK476083A (en) 1984-12-24
GB8317022D0 (en) 1983-07-27

Similar Documents

Publication Publication Date Title
DK130791A (en) MONOCLONAL ANTIBODIES, ISAES FOR HB ALC.
AR243931A1 (en) Purified antigen, set of reagents for detecting anti-hiv-2 antibodies in a biological fluid that contains these antigens, antibodies, hybridomas and the procedures involved.
CU22615A1 (en) PROCEDURE FOR OBTAINING LESS IMMUNOGENIC MONOCLONAL ANTIBODIES. MONOCLONAL ANTIBODIES OBTAINED
DK0523395T3 (en) Seroreactive regions on proteins E1 and E2 in HPV 16
DK392387D0 (en) MONOCLONAL ANTIBODY FOR DIAGNOSTIC USE AND PROCEDURE FOR MANUFACTURING SUCH ANTIBODY
GB2188941B (en) Monoclonal antibodies recognizing human interleukin-2-receptor
EP0232179A3 (en) Assay for human breast cancer
DE69034254D1 (en) A-PDGF RECEPTOR AND ITS USE
DE69024043D1 (en) MONOCLONAL ANTIBODY WITH DETECTING SPECIFICITY FOR A GLYCOPROTEIN OF GLOBULAR MEMBRANE-MUCIN ANTIGENS FROM HUMAN MILK FAT.
NO175639C (en) Peptide, antibody obtained by the peptide, a method for immunologically determining intact procollagen peptide (type III) and use of the peptide
FR2563630B1 (en) ANTICYTOMEGALOVIRUS MONOCLONAL ANTIBODIES AND METHODS FOR THE IN VITRO DIAGNOSIS OF HUMAN CYTOMEGALOVIRUS AND CYTOMEGALOVIRUS PROTEIN KINASE INFECTIONS WHICH CAN BE RECOGNIZED BY MONODOCONUS SUSPICY
EP0834567A3 (en) Compounds and methods for the diagnosis and treatment of Babesia microti infection
DE69026875D1 (en) IMMUNE DETERMINATION OF HUMAN OSTEOCALCIN, REAGENT AND SET THEREFOR
FI922666A0 (en) DIAGNOSTIC FOERFARANDE.
EP0845540A4 (en) MONOCLONAL ANTIBODIES AND ANTIGEN RELATING TO HUMAN PULMONARY ADENOCARCIMOMA AND METHOD OF IMMUNOASSAY USING THIS ANTIBODY AND ANTIGEN
EP0293827A3 (en) Assay for leishmaniasis
SE9000931D0 (en) ANTIBODIES AGAINST PROTEINS
ATE106945T1 (en) METHODS AND MATERIALS FOR HIV DETECTION AND THERAPY.
ATE73463T1 (en) MONOCLONAL ANTIBODIES.
SE8305667D0 (en) ADENOCARCINOMA RELATED NEW ANTIGENIC DETERMINANTS AND ANTIBODIES SPECIFIC THERETO, PROCESSES FOR THEIR PREPARATION AND REAGENT SYSTEMS PERTAINING TO THEM
ATE125306T1 (en) MONOCLONAL ANTIBODIES THAT MAKE A DIFFERENCE BETWEEN NATIVE PROTEINS AND PROTEINS WITH A MODIFIED SEQUENCE.
RU97114296A (en) METHOD FOR PRODUCING DIAGNOSTIC SERUM
FR2601037B1 (en) PEPTIDE HAVING ISOLATED ANTIGENIC PROPERTIES OF PROTEIN 28 KD FROM S. MANSONI AND ITS ISOLATION METHOD, MONOCLONAL ANTIBODIES RECOGNIZING AT LEAST ONE EPITOPE OF SAID PEPTIDE AND APPLICATION OF SAME IN THE INDUCTION OF ANTIBODY SYNTHESIS
UA49257A (en) Method for producing species-specific agglutinating serum against brucella ovis

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: FARMITALIA CARLO ERBA

Effective date: 19860430